Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Short Term Loans and Advances

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Short Term Loans and Advances History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Short Term Loans and Advances ₹616 Cr₹804 Cr₹276 Cr₹294 Cr₹209 Cr

What is the latest Short Term Loans and Advances ratio of MANKIND PHARMA ?

The latest Short Term Loans and Advances ratio of MANKIND PHARMA is ₹616 Cr based on Mar2023 Consolidated results.
Year Short Term Loans and Advances
Mar2023₹616 Cr
Mar2022₹804 Cr
Mar2021₹276 Cr
Mar2020₹294 Cr
Mar2019₹209 Cr

How is Short Term Loans and Advances of MANKIND PHARMA Trending?

Years Short Term Loans and Advances % Change
Mar2023 ₹616 Cr
-23.44
Mar2022 ₹804 Cr
191.64
Mar2021 ₹276 Cr
-6.26
Mar2020 ₹294 Cr
40.65
Mar2019 ₹209 Cr -

Compare Short Term Loans and Advances of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹83,865.6 Cr -4% -8.3% 51.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹367,470.0 Cr 0.4% -0.4% 61.2% Stock Analytics
CIPLA ₹112,990.0 Cr -1.1% 1.7% 53.9% Stock Analytics
ZYDUS LIFESCIENCES ₹105,846.0 Cr 5.9% 11.3% 94.8% Stock Analytics
DIVIS LABORATORIES ₹103,849.0 Cr -0.1% 3.9% 20% Stock Analytics
DR REDDYS LABORATORIES ₹96,742.1 Cr -2% -4.2% 29.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-4%

-8.3%

51.1%

SENSEX

1.7%

0.7%

19.2%


You may also like the below Video Courses